Cell Therapy is Reshaping the Landscape of the Orthopedics Field, As Industry Giants are Rushing to Place Bets, with Numerous Phase II/III Pipelines Clustered in this Track.
Cell therapy is expected to provide a fundamental solution to this dilemma. Mesenchymal stem cells (MSCs) are a type of adult stem cells with self-renewal and multi-directional differentiation capabilities, with low immunogenicity. Through paracrine and immunomodulatory mechanisms, they can play roles in tissue injury repair, hematopoietic support, nutritional supply, activation of endogenous stem/progenitor cells, immunoregulation, promotion of angiogenesis, and anti-fibrosis.
Source: European Central Station
